New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors
Carbonic Anhydrases (CAs) are ubiquitous metalloenzymes involved in several disease conditions. There are 15 human CA (hCA) isoforms and their high homology represents a challenge for the discovery of potential drugs devoid of off-target side effects. For this reason, many synthetic and pharmacologi...
Main Authors: | Andrea Angeli, Victor Kartsev, Anthi Petrou, Mariana Pinteala, Roman M. Vydzhak, Svitlana Y. Panchishin, Volodymyr Brovarets, Viviana De Luca, Clemente Capasso, Athina Geronikaki, Claudiu T. Supuran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/8/828 |
Similar Items
-
Carbonic Anhydrase Inhibition with Sulfonamides Incorporating Pyrazole- and Pyridazinecarboxamide Moieties Provides Examples of Isoform-Selective Inhibitors
by: Andrea Angeli, et al.
Published: (2021-11-01) -
Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties
by: Andrea Angeli, et al.
Published: (2021-05-01) -
Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors
by: Andrea Angeli, et al.
Published: (2023-04-01) -
Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors
by: Pavitra S. Thacker, et al.
Published: (2019-01-01) -
Carbonic Anhydrases: Versatile and Useful Biocatalysts in Chemistry and Biochemistry
by: Andrea Angeli, et al.
Published: (2020-09-01)